0338-0080 : Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal
NDC: | 0338-0080 |
Labeler: | Baxter Healthcare Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Doxorubicin Hydrochloride Liposome |
Dosage Form: | Intravenous Injection, Suspension, Liposomal |
Application #: | NDA050718 |
Rev. Date: |
NDC Package Codes:
- 0338-0080-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (0338‑0080‑01) > 10 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Doxorubicin Hydrochloride
Dosage Strength:
- 2 mg/mL
Pharmaceutical Classes:
- Anthracycline Topoisomerase Inhibitor [EPC]
- Anthracyclines [CS]
- Topoisomerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0338-0086 Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
- 59676-966 Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Janssen Products, Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0338-0078Next: 0338-0081 >
Related Discussions:
Amphotericin B Liposomal
300 mg...
300 mg...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.